DE602004006725D1 - Reinigung von Antikörpern durch Protein A und Ionenaustauschromatographie - Google Patents

Reinigung von Antikörpern durch Protein A und Ionenaustauschromatographie

Info

Publication number
DE602004006725D1
DE602004006725D1 DE602004006725T DE602004006725T DE602004006725D1 DE 602004006725 D1 DE602004006725 D1 DE 602004006725D1 DE 602004006725 T DE602004006725 T DE 602004006725T DE 602004006725 T DE602004006725 T DE 602004006725T DE 602004006725 D1 DE602004006725 D1 DE 602004006725D1
Authority
DE
Germany
Prior art keywords
protein
antibodies
purification
ion exchange
exchange chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004006725T
Other languages
English (en)
Other versions
DE602004006725T2 (de
Inventor
Julian Bonnerjea
Anna Preneta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza Biologics PLC
Original Assignee
Lonza Biologics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9953825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004006725(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lonza Biologics PLC filed Critical Lonza Biologics PLC
Priority claimed from PCT/EP2004/002041 external-priority patent/WO2004076485A1/en
Publication of DE602004006725D1 publication Critical patent/DE602004006725D1/de
Application granted granted Critical
Publication of DE602004006725T2 publication Critical patent/DE602004006725T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE602004006725T 2003-02-28 2004-03-01 Reinigung von Antikörpern durch Protein A und Ionenaustauschromatographie Expired - Lifetime DE602004006725T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0304576.2A GB0304576D0 (en) 2003-02-28 2003-02-28 Protein a chromatography
GB0304576 2003-02-28
PCT/EP2004/002041 WO2004076485A1 (en) 2003-02-28 2004-03-01 Antibody purification by protein a and ion exchange chromatography

Publications (2)

Publication Number Publication Date
DE602004006725D1 true DE602004006725D1 (de) 2007-07-12
DE602004006725T2 DE602004006725T2 (de) 2008-02-07

Family

ID=9953825

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004006725T Expired - Lifetime DE602004006725T2 (de) 2003-02-28 2004-03-01 Reinigung von Antikörpern durch Protein A und Ionenaustauschromatographie

Country Status (9)

Country Link
US (3) US20060030696A1 (de)
JP (2) JP2007525412A (de)
KR (1) KR101200732B1 (de)
CN (1) CN100384874C (de)
AT (1) ATE363491T1 (de)
DE (1) DE602004006725T2 (de)
ES (1) ES2288252T3 (de)
GB (1) GB0304576D0 (de)
TW (1) TWI325428B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658773B2 (en) 2011-05-02 2014-02-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
US20160279239A1 (en) 2011-05-02 2016-09-29 Immunomedics, Inc. Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
GB0220894D0 (en) * 2002-09-09 2002-10-16 Millipore Uk Ltd Method of separation
GB0304576D0 (en) * 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
WO2005077528A1 (en) * 2004-02-05 2005-08-25 Millipore Corporation Porous adsorptive or chromatographic media
BRPI0516572A (pt) * 2004-10-05 2008-09-16 Wyeth Corp métodos e composições para melhorar a produção de proteìnas recombinantes
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
RU2457214C2 (ru) * 2005-03-11 2012-07-27 Вайет Способ хроматографии в режиме слабого распределения
CN104926938B (zh) 2005-06-17 2019-06-04 惠氏有限责任公司 纯化含Fc区蛋白的方法
ZA200900837B (en) * 2006-08-28 2010-05-26 Ares Trading Sa Process for the purification of FC-containing proteins
AU2008256411B2 (en) 2007-06-01 2013-08-22 F. Hoffmann-La Roche Ag Immunoglobulin purification
US9433922B2 (en) * 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
US20090130738A1 (en) * 2007-11-19 2009-05-21 Mikhail Kozlov Media for membrane ion exchange chromatography
US20090286283A1 (en) * 2008-05-16 2009-11-19 Samsung Electronics Co., Ltd. Method and affinity column for purifying proteins
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
EP2335076B1 (de) * 2008-09-15 2012-08-08 EMD Millipore Corporation Verfahren zur quantifizierung des proteinverlusts von affinitätschromatographieharzen auf proteinbasis
JP5626526B2 (ja) 2008-09-25 2014-11-19 Jsr株式会社 アフィニティークロマトグラフィー用充填剤
US10419541B2 (en) 2008-11-26 2019-09-17 Free Stream Media Corp. Remotely control devices over a network without authentication or registration
EP2360183B1 (de) 2008-12-19 2016-07-27 Takeda Pharmaceutical Company Limited Antikörperreinigungsverfahren mittels "mixed-mode" chromatography unter verwendung einer arginine-haltigen beladungslösung
JP2012513425A (ja) 2008-12-22 2012-06-14 エフ．ホフマン−ラ ロシュ アーゲー 免疫グロブリンの精製
SG162687A1 (en) * 2008-12-24 2010-07-29 Millipore Corp Caustic stable chromatography ligands
KR20190018041A (ko) 2009-08-06 2019-02-20 제넨테크, 인크. 단백질 정제 시의 바이러스 제거의 개선방법
IN2012DN00338A (de) * 2009-08-07 2015-05-22 Millipore Corp
EP2478005B1 (de) * 2009-09-15 2014-11-12 Ajinomoto Althea, Inc. Protein-a-kristalle und vernetzte kristalle sowie verwendungsverfahren dafür
AU2010310748C1 (en) 2009-10-20 2015-11-26 Abbvie Inc. Isolation and purification of anti-IL-13 antibodies using Protein A affinity chromatography
WO2011073389A1 (en) 2009-12-18 2011-06-23 Novartis Ag Wash solution and method for affinity chromatography
EP2519537A4 (de) * 2009-12-29 2013-07-10 Reddys Lab Ltd Dr Reinigung von proteinen
EP2583973B1 (de) * 2010-06-21 2018-03-21 Kyowa Hakko Kirin Co., Ltd. Verfahren zur reinigung von proteinen mit aminosäuren
CN103189390A (zh) * 2010-11-01 2013-07-03 帝斯曼知识产权资产管理有限公司 单一单元离子交换色谱抗体纯化
MX357821B (es) * 2010-12-21 2018-07-25 Hoffmann La Roche Preparación de anticuerpo enriquecida con isoforma y método para obtenerla.
IL212911A0 (en) * 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
WO2012160536A1 (en) * 2011-05-26 2012-11-29 Dr Reddy's Laboratories Limited Antibody purification
SG10201604554WA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
WO2013009526A1 (en) * 2011-07-08 2013-01-17 Merck Sharp & Dohme Corp. Method for purifying fc-fusion protein
WO2013028330A2 (en) * 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
CN104066748A (zh) * 2011-11-21 2014-09-24 霍夫曼-拉罗奇有限公司 抗c-met抗体的纯化
EP2791176B1 (de) * 2011-12-15 2018-07-11 Prestige Biopharma Pte. Ltd. Verfahren zur antikörperreinigung
EP2682168A1 (de) * 2012-07-02 2014-01-08 Millipore Corporation Reinigung biologischer Moleküle
CN103073616A (zh) * 2013-01-06 2013-05-01 西北大学 使用混合模式层析技术去除抗体聚集体的方法
RU2646098C2 (ru) 2013-04-30 2018-03-01 Интас Фармасьютикалс Лтд Новый способ клонирования, экспрессии и очистки для получения ранибизумаба
EP3048109A4 (de) * 2013-09-17 2017-04-19 Kaneka Corporation Neuartiges antikörperaufreinigungsverfahren und antikörper daraus sowie neuartiges antikörperaufreinigungsverfahren unter verwendung eines kationenaustauschers und antikörper daraus
KR102123700B1 (ko) * 2013-12-17 2020-06-16 (주)셀트리온 혼합 방식 크로마토그래피를 이용한 침출된 단백질 a 제거 방법
JP6612242B2 (ja) * 2014-02-14 2019-11-27 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ 自動化された多段階精製システム及び多段階クロマトグラフィー精製方法
EP3118210B1 (de) * 2014-03-11 2019-11-13 Green Cross Holdings Corporation Verfahren zur aufreinigung von immunglobulin
ES2785375T3 (es) * 2014-03-11 2020-10-06 Green Cross Holdings Corp Procedimiento de purificación de inmunoglobulina
WO2015138548A1 (en) * 2014-03-14 2015-09-17 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
JP6451118B2 (ja) * 2014-07-17 2019-01-16 東ソー株式会社 抗体の分離方法
KR101672947B1 (ko) 2015-03-17 2016-11-04 주식회사 비에스엘 상황 알림 기능을 가진 히어링 디바이스 및 그에 의한 상황 알림 방법
US20160280767A1 (en) 2015-03-23 2016-09-29 Lonza Ltd. Methods for controlling protein glycosylation
AU2016288678B2 (en) 2015-06-30 2021-05-27 Vapotherm, Inc. Nasal cannula for continuous and simultaneous delivery of aerosolized medicament and high flow therapy
US11186858B1 (en) 2016-03-15 2021-11-30 Fresenius Kabi Deutschland Gmbh Methods for increasing biosimilarity
US10688412B2 (en) 2016-07-25 2020-06-23 Cehpalon, Inc. Affinity chromatography wash buffer
CN106380519B (zh) * 2016-10-17 2019-11-01 深圳万乐药业有限公司 一种单克隆抗体的纯化方法
WO2018187074A1 (en) 2017-04-03 2018-10-11 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy
US11724056B2 (en) 2017-09-08 2023-08-15 Vapotherm, Inc. Birfurcated cannula device
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
EP3816177A4 (de) * 2018-06-29 2021-12-01 Mitsubishi Chemical Corporation Verfahren zur polypeptidisolierung, verfahren zur polypeptidherstellung und vorrichtung zur polypeptidreinigung
CN109324143B (zh) * 2018-10-19 2021-10-29 张骐 利用二维液相分离制备抗体类产品相关杂质的方法
BR112021026256A2 (pt) 2019-06-28 2022-03-03 Vapotherm Inc Cânula de geometria variável
MX2022003715A (es) 2019-09-26 2022-07-11 Vapotherm Inc Nebulizador montado en cánula interna.

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1201063A (en) 1982-07-20 1986-02-25 Winnipeg Rh Institute Inc., (The) Process for preparing purified immune globulin (igg)
US5089605A (en) 1987-03-13 1992-02-18 Repligen Corporation Immobilized immunoglobulin-binding proteins
EP0289129A3 (de) 1987-03-26 1990-10-10 Repligen Corporation Herstellung von hochgereinigtem Protein A
US5084559A (en) * 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants
US5118796A (en) 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5115101A (en) * 1988-06-08 1992-05-19 Miles Inc. Removal of protein A from antibody preparations
US4983722A (en) 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
US5650319A (en) * 1990-04-20 1997-07-22 Teijin Limited Human monoclonal antibody to glycoprotein GPIII of varicella zoster virus
DE69127043T2 (de) 1990-04-20 1998-02-19 Teijin Ltd Menschliche monoklonale antikörper gegen gpiii des varizella-zoster-virus
GB9022547D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Purified immunoglobulin
WO1992018629A1 (en) 1991-04-19 1992-10-29 Genetics Institute, Inc. Recombinant 3f8-type antibodies
EP0752248B1 (de) * 1992-11-13 2000-09-27 Idec Pharmaceuticals Corporation Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma
JPH07155194A (ja) 1993-12-10 1995-06-20 Teijin Ltd タンパク質の精製法
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
SE9503925D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
US6013763A (en) 1996-06-04 2000-01-11 Genentech, Inc. Peptide variants of protein A
JP2001502895A (ja) * 1996-09-20 2001-03-06 ザ・ジェネラル・ホスピタル・コーポレイション アルファ―２―抗プラスミンに対するキメラ、ヒト化および一本鎖抗体
CA2289665C (en) 1997-06-13 2005-08-09 Genentech, Inc. Protein recovery by chromatography followed by filtration upon a charged layer
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
TW505655B (en) 1997-10-14 2002-10-11 Tanox Inc Enhanced aggregate removal from bulk-biologicals using ion exchange chromatography
US6504013B1 (en) 2000-02-01 2003-01-07 Idexx Laboratories, Inc. Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
AU756889B2 (en) * 1998-04-22 2003-01-23 Genvec, Inc. Efficient purification of adenovirus
EP1500661A1 (de) 1998-06-01 2005-01-26 Genetech, Inc. Trennung von Protein-Monomeren von Aggregaten mittels Ionaustausch-Chromatographie
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
WO2002096948A2 (en) * 2001-01-29 2002-12-05 Idec Pharmaceuticals Corporation Engineered tetravalent antibodies and methods of use
DE60231651D1 (de) * 2001-12-21 2009-04-30 Immunex Corp Proteinreinigungsverfahren
JP4319979B2 (ja) * 2002-04-26 2009-08-26 ジェネンテック・インコーポレーテッド タンパク質の非アフィニティ精製
GB0304576D0 (en) * 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
EP1601697B1 (de) 2003-02-28 2007-05-30 Lonza Biologics plc Reinigung von Antikörpern durch Protein A und Ionenaustauschromatographie
JPWO2004087761A1 (ja) * 2003-03-31 2006-07-27 麒麟麦酒株式会社 ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
AU2004286938B2 (en) * 2003-10-27 2011-06-30 Wyeth Removal of high molecular weight aggregates using hydroxyapatite chromatography
KR20070072510A (ko) 2004-08-30 2007-07-04 론자 바이올로직스 피엘씨 항체 정제를 위한 친화도- 및 이온 교환- 크로마토그래피

Also Published As

Publication number Publication date
US20060030696A1 (en) 2006-02-09
CN100384874C (zh) 2008-04-30
JP5752558B2 (ja) 2015-07-22
US20060194953A1 (en) 2006-08-31
US7847071B2 (en) 2010-12-07
CN1771260A (zh) 2006-05-10
ES2288252T3 (es) 2008-01-01
KR101200732B1 (ko) 2012-11-13
US20110040075A1 (en) 2011-02-17
DE602004006725T2 (de) 2008-02-07
JP2007525412A (ja) 2007-09-06
ATE363491T1 (de) 2007-06-15
GB0304576D0 (en) 2003-04-02
JP2012067108A (ja) 2012-04-05
KR20050113617A (ko) 2005-12-02
TW200530265A (en) 2005-09-16
TWI325428B (en) 2010-06-01

Similar Documents

Publication Publication Date Title
ATE363491T1 (de) Reinigung von antikörpern durch protein a und ionenaustauschromatographie
DE60231651D1 (de) Proteinreinigungsverfahren
CY1119024T1 (el) Καθαρισμος πρωτεϊνης
DK1308456T3 (da) Antistofoprensning ved ionbytterkromatografi
DK1601697T3 (da) Oprensning af antistof ved protein A- og ionbytningskromatografi
DK1888636T3 (da) Fremgangsmåde til oprensning af antistoffer
BRPI0611600B8 (pt) método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit
MX9603637A (es) Purificacion de anticuerpo.
WO2002083710A3 (en) Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
DK0998486T4 (da) Proteinoprensning ved kromatografi efterfulgt af filtrering på en ladet fase
EE200700052A (et) Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu
DE60334460D1 (de) Antikörper spezifisch für das tau-protein des zentralen nervensystems
DE69633563D1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
DK1881064T3 (da) HCV-anti-kerne monoklonalt antistof
DK1273592T3 (da) Fremgangsmåde til oprensning af interferonproteiner ved hjælp af kationbytningskromatografi
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
DE50208601D1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
DK1115745T3 (da) Oprensning af fibrinogen fra væsker ved udfældning og hydrofob interaktionskromatografi
ATE206140T1 (de) Polyklonaler antikörper gegen tryptase und reinigungsverfahren zur verwendung in einem immunoassay für menschliche tryptase
ATE417056T1 (de) Verfahren zur proteinreinigung
ATE437181T1 (de) Reinigung glucagonähnlicher peptide
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
MY137572A (en) Antibody purification by protein a and ion exchange chromatography
ATE294237T1 (de) S?ugetier thymokingene
DK1456228T3 (da) Fremgangsmåde til isolering og rensning af trypsin fra pronase samt dens anvendelse

Legal Events

Date Code Title Description
8363 Opposition against the patent